Medical Equipment

Heart Defect Closure Device Market Trends, Drivers, and Regional Analysis 2025–2029

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the heart defect closure device market from 2025–2034 with trusted insights from The Business Research Company

How Is The Heart Defect Closure Device Market Size Expected To Expand Over 2029-2034?

The heart defect closure device market has seen considerable expansion in its size over recent years. It is projected to expand from $1.11 billion in 2024 to $1.27 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 13.8%. This historical expansion can be traced back to several factors, including an increasing number of individuals living with congenital heart problems, an aging demographic, heightened health awareness, a rise in research and development activities, and significant advancements in catheterization techniques.

The heart defect closure device market is poised for significant expansion over the coming years. Its valuation is anticipated to reach $2.12 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 13.7%. This projected growth can be attributed to an increase in congenital defects, enhancements in diagnostic methodologies, wider adoption of MRI procedures, greater utilization of 3D imaging in heart defect closure processes, and a high incidence of ischemic stroke. Noteworthy trends expected during the forecast period encompass technological progress, the creation of novel products, the emergence of next-generation heart closure devices, an expanding identification of PFO closure devices, and the necessity to evaluate the advantages of PFO closure for older demographics.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16074&type=smp

Which Market Factors Are Fueling The Heart Defect Closure Device Industry Growth?

The escalating number of individuals afflicted with congenital heart problems is anticipated to drive the expansion of the heart defect closure device market moving forward. Congenital heart problems are structural defects of the heart present at birth, often resulting from genetic predispositions, environmental factors, and maternal health conditions like diabetes, obesity, or exposure to specific medications or infections during pregnancy. Heart defect closure devices play a crucial role in treating these conditions by offering minimally invasive solutions to seal irregular heart openings, which in turn restores normal blood flow, lessens complications, and improves overall cardiac function. Illustratively, an article published by the National Library of Medicine (NLM) in October 2024 indicated a sharp increase in the incidence rate of CHD, reaching 5.46% in 2023, up from 1.12% in 2020, 2.36% in 2021, and 3.87% in 2022. This growing prevalence of congenital heart problems is therefore a primary driver for the heart defect closure device market.

Which Categories Are Covered In The Heart Defect Closure Device Market Segmentation Analysis?

The heart defect closure devicemarket covered in this report is segmented –

1) By Type: Atrial Septal Defect (ASD) Closure Device, Left Atrial Appendage (LAA) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices

2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials

3) By Mode Of Delivery: Transcatheter Delivery, Surgical Delivery, Other Modes

4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Atrial Septal Defect (ASD) Closure Device: Occluder Devices (Septal Occluders), Implantable Patch Devices, Self-Expanding Devices, Balloon-Expandable Devices

2) By Left Atrial Appendage (LAA) Closure Devices: Occluder Devices (WATCHMAN Device), Clip-Based Devices, Self-Expanding LAA Closure Devices

3) By Patent Foramen Ovale (PFO) Closure Devices: Septal Occluders, Self-Expanding Occluders, Balloon-Expandable Occluders

4) By Patent Ductus Arteriosus (PDA) Closure Devices: Coil-Based Closure Devices, Stent-Based Closure Devices, Amplatzer Occluders

5) By Ventricular Septal Defect (VSD) Closure Devices: Septal Occluder Devices, Balloon-Expandable Occluders, Self-Expanding Occluders

Which Market Trends Are Expected To Define The Future Of The Heart Defect Closure Device Market?

Leading firms within the heart defect closure device sector are creating self-expanding, double-disc occluders, offering a minimally invasive method to seal cardiac defects. These self-expanding, double-disc devices boost procedural safety, better patient results through shorter recovery periods, and lower the likelihood of complications linked to conventional open-heart operations. As an illustration, in September 2022, Abbott Laboratories, a medical devices and health care company based in the US, introduced the Amplatzer Talisman PFO Occlusion System across Europe. This Amplatzer Talisman PFO Occlusion System is a medical apparatus engineered to seal a patent foramen ovale (PFO), which is an atypical opening between the heart’s left and right atria, capable of causing strokes and other issues. The system employs a minimally invasive technique to place a self-expanding, double-disc occluder, crafted from nitinol wire mesh, thereby effectively sealing the PFO and hindering clot movement between the atria.

Which Organizations Are At The Forefront Of The Heart Defect Closure Device Market?

Major companies operating in the heart defect closure device market are Abbott Laboratories, Medtronic, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences, W L Gore and Associates, B. Braun, BIOTRONIK SE & Co. KG, Lepu Medical Technology, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, AtriCure Inc., LifeTech Scientific Corporation, Baylis Medical Company Inc., Biosense Webster Inc., Sahajanand Medical Technologies Limited, Occlutech, Coherex Medical Inc., Cardia Inc., Acrostak Corporation, Vivasure Medical, Transmural Systems Inc., Cormatrix Cardiovascular Inc., and St. Jude Medical LLC.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report

Which Geographic Areas Are Driving Strong Demand For The Heart Defect Closure Device Market?

North America was the largest region in the heart defect closure device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart defect closure device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=16074&type=smp

Browse Through More Reports Similar to the Global Heart Defect Closure Device Market 2025, By The Business Research Company

Prosthetic Heart Valve Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report

Hearth Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hearth-global-market-report

Flea Tick And Heartworm Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/flea-tick-and-heartworm-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795